๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

High plasma fibrinogen level is associated with poor clinical outcome in DIC patients

โœ Scribed by Hideo Wada; Yoshitaka Mori; Kazuhiro Okabayashi; Esteban C Gabazza; Fumihiko Kushiya; Masato Watanabe; Masakatsu Nishikawa; Hiroshi Shiku; Tsutomu Nobori

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
100 KB
Volume
72
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Met expression is associated with poor o
Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma
โœ Robert L. Camp; Eric B. Rimm; David L. Rimm ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 244 KB ๐Ÿ‘ 2 views

## BACKGROUND. Activation of Met, the receptor for scatter factor/hepatocyte growth factor, is associated with mitogenesis, motogenesis, and decreased cell adhesion. Elevated expression of Met has been shown in advanced cases of carcinoma of the prostate, stomach, pancreas, and thyroid. The author

High levels of tissue inhibitor of metal
High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer
โœ Kevin McCarthy; Teresa Maguire; Gerald McGreal; Enda McDermott; Niall O'Higgins; ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 67 KB ๐Ÿ‘ 1 views

Studies from model systems suggest that matrix metalloproteinases (MMPs) are causally involved in tumor progression while tissue inhibitors of MMPs (TIMPs) prevent this progression. Here, we show that concentrations of TIMP-1 are significantly higher in breast carcinomas than in fibroadenomas. In pr

High pre-treatment serum level of vascul
High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer
โœ Petri Salven; Tarja Ruotsalainen; Karin Mattson; Heikki Joensuu ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 68 KB ๐Ÿ‘ 1 views

Vascular endothelial growth factor (VEGF) is an important regulator of angiogenesis and vascular permeability. Increased serum VEGF concentrations (S-VEGF) have been found in patients with various types of human cancer, including cancer of the lung. However, the clinical and prognostic significance